Afatinib monotherapy in patients with metastatic squamous cell carcinoma of the lung progressing after erlotinib/gefitinib (E/G) and chemotherapy: Interim subset analysis from a phase III trial.
Joo-Hang Kim
Research Funding - Boehringer Ingelheim
Francesco Grossi
Honoraria - Boehringer Ingelheim
Filippo De Marinis
No relevant relationships to disclose
Manuel Cobo
No relevant relationships to disclose
James Chih-Hsin Yang
Consultant or Advisory Role - Boehringer Ingelheim (U)
Honoraria - Boehringer Ingelheim
Yury Ragulin
No relevant relationships to disclose
Igor N. Bondarenko
No relevant relationships to disclose
Vikram K. Chand
Employment or Leadership Position - Boehringer Ingelheim
Bushi Wang
Employment or Leadership Position - Boehringer Ingelheim
Edith Gracien
Employment or Leadership Position - Boehringer Ingelheim
Martin H. Schuler
Consultant or Advisory Role - Boehringer Ingelheim
Research Funding - Boehringer Ingelheim; Roche